Frequently Asked Questions

Semaglutide is a single-action GLP-1 receptor agonist available under brand names like Ozempic (for diabetes) and Wegovy (for weight management). Tirzepatide is a dual-action medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, available as Mounjaro and Zepbound. Clinical studies suggest that Tirzepatide may produce slightly greater average weight loss compared to Semaglutide, though both medications have demonstrated significant efficacy. Both are administered as once-weekly injections, and your healthcare provider will recommend the most suitable option based on your individual health profile.

Yes, certain GLP-1 medications have received explicit FDA approval for chronic weight management. Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are both approved specifically for weight loss in adults who meet the clinical criteria. Other GLP-1 medications like Ozempic and Mounjaro are FDA-approved for type 2 diabetes but are sometimes prescribed off-label for weight management at the discretion of a licensed healthcare provider.

The most frequently reported side effects include nausea, diarrhea, constipation, vomiting, and abdominal discomfort. These gastrointestinal effects are typically mild to moderate and tend to diminish as your body adjusts to the medication over the first several weeks. Gradual dose escalation is the standard approach to minimize these effects. Less common but more serious side effects can include pancreatitis, gallbladder issues, and allergic reactions. Your prescribing physician will discuss potential risks with you and monitor for any adverse effects throughout your treatment.

Generally, GLP-1 medications for weight loss are prescribed to adults aged 18 and older with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition such as type 2 diabetes, hypertension, or high cholesterol. Individuals who are pregnant, breastfeeding, or who have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 are typically not eligible. A licensed healthcare provider will conduct a thorough evaluation during your consultation to confirm your eligibility.

Online GLP-1 programs typically follow a straightforward process: you complete an online health assessment, a licensed physician reviews your information and conducts a virtual consultation, and if approved, a prescription is issued and the medication is shipped directly to your home. Most programs include ongoing medical support with regular check-ins to monitor your progress and adjust dosages as needed. The entire process is designed to be convenient, private, and accessible from anywhere in the United States.

No, the majority of online GLP-1 programs do not require health insurance. They operate on a self-pay model with transparent monthly pricing that typically includes the medical consultation, prescription, medication, and shipping. Some programs do accept insurance for eligible patients, and many allow payment through Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA). Compounded medication options tend to be significantly more affordable for self-pay patients compared to brand-name alternatives.

Compounded GLP-1 medications are legal when prepared by FDA-registered 503A or 503B compounding pharmacies and prescribed by a licensed healthcare provider. These pharmacies operate under strict regulatory oversight and quality control standards. While compounded medications are not FDA-approved in the same manner as their brand-name counterparts, they provide a more affordable alternative, especially during periods of brand-name medication shortages. Choosing a reputable program that partners with licensed compounding pharmacies is essential for safety and efficacy.

Monthly costs vary significantly depending on the provider and medication type. Compounded GLP-1 medications generally range from $99 to $299 per month through online programs, while brand-name medications such as Wegovy or Zepbound can exceed $1,000 per month without insurance coverage. Most online programs bundle the physician consultation, prescription, medication, and home delivery into a single monthly fee with no hidden charges. We recommend reviewing our program comparisons to find the best value for your budget and treatment needs.

Most patients begin to notice a decrease in appetite and some initial weight loss within the first 2 to 4 weeks of treatment. More significant and visible results typically develop after 8 to 12 weeks as the medication dosage is gradually increased to therapeutic levels. Clinical trials have demonstrated the most substantial outcomes after 6 to 12 months of consistent use. Individual results will vary depending on factors such as starting weight, adherence to the treatment plan, dietary habits, and physical activity levels.

Most online GLP-1 programs operate on a month-to-month basis and allow cancellation at any time before the next billing cycle. There are generally no long-term contracts or cancellation penalties. However, specific cancellation policies may vary between providers, so it is advisable to review the terms of service for your chosen program before enrolling. If you plan to discontinue GLP-1 treatment, consult your healthcare provider for guidance on safely tapering off the medication rather than stopping abruptly.